Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Thomas R. Collins

Tom Collins is a freelance writer in South Florida, who has written about medical topics from nasty infections to ethical dilemmas, runaway tumors to tornado-chasing doctors. He travels the globe gathering conference health news and lives in West Palm Beach.

Articles by Thomas R. Collins

EULAR 2014: Biosimilar Drug Production Raises Concerns

Thomas R. Collins  |  August 1, 2014

Rheumatology experts question biosimilars’ safety, efficacy given their complex production process

EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis

Thomas R. Collins  |  August 1, 2014

Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA

How the Idea of Autoimmunity Emerged

Thomas R. Collins  |  June 1, 2014

A rheumatologist at the ACR’s State-of-the-Art Clinical Symposium in Chicago recalls history of immunology, urges scientists to further explore relationship between autoimmunity, microbiomes

What’s New in Inflammatory Arthritis?

Thomas R. Collins  |  June 1, 2014

Rheumatology experts at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss latest drug therapies, insights into axial spondyloarthritis and bone erosion, repair

New Osteoporosis Drugs Show Promise in Therapy Pipeline

Thomas R. Collins  |  June 1, 2014

Rheumatologists at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss medication alternatives to bisphosphonates that reduce bone resorption, build bone density and may provide new treatment options

Expansion of Mobile Health Apps Makes Physicians’ Job Easier

Thomas R. Collins  |  April 2, 2014

Rheumatologists choose, review top mobile health devices

Tech Talk: Physicians Debate Using Cell Phones to Communicate with Patients

Thomas R. Collins  |  November 1, 2013

Concerns about protecting personal privacy and receiving after-hours calls are balanced by physicians’ desire to connect with patients

EULAR 2013: New RA Recommendations Address Combination Therapy Concerns

Thomas R. Collins  |  October 1, 2013

Guidelines give greater nod to use of combination conventional disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, leave monotherapy with methotrexate as acceptable first-line treatment

Tech Talk: New Technologies Attempt to Find Better Treatments for Rheumatic Diseases

Thomas R. Collins  |  September 1, 2013

Research in proteomics and genetics sheds new light on treatment strategies, brings potential for breakthroughs

EULAR 2013: Researchers Expand Targets for PsA, OA Therapy

Thomas R. Collins  |  September 1, 2013

Experts discuss insights in the pathogenesis of psoriatic arthritis and the role of subchondral bone in osteoarthritis

  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 31
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences